References
- Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7
- Ferrannini E., Santoro D., Manicardi V. The association of essential hypertension and diabetes. Compr Ther 1989; 15: 51–8
- Baum M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 1987; 79: 1104–1109
- De Fronzo RA. Insulin and renal sodium handling:clinical implications. International Journal of Obesity 1981; 5: 93–104
- Carretta R, Fabris B, Fischetti F, Costantini M, De Biasi F, Muiesan S, et al. Reduction of blood pressure in obese hyperinsulinaemic hypertensive patients during somatostatin infusion. J Hypertens 1989, Suppl, 7: S196–S197
- Hall JE, Coleman TG, Lel Mizelle H. Does chronic hyperinsulinemia cause hypertension?. Am J Hypertens 1989; 2: 171–173
- Fagerberg B. On the hypotensive response to weight reduction. University of Gothenburg. 1984, Thesis
- Modan M, Almog S, Fuchs Z, Chterit A, Lusky A, Halkin H. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension 1991; 17: 565–73
- Isaksson H., Nygren A., Östergren J. Characteristics of patients resistant to antihypertensive drug therapy. J Int Med 1991; 229: 421–6
- Isaksson H, Nygren A, Östergren J. Poor response to antihypertensive therapy associated with insulin resistance. 1991, ESH:s Fifth European Meeting on Hypertension, Milan Abstract
- Lightman SL, Fox P, Dunne MJ. The effects of SMS 201–995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers. Scand J Gastroent. 1986; 21: 84–95
- Jenner DA, Beilin LJ, Vandongen R, DeKlerk NH. A comparison of blood pressure measurements obtained with the Dinamap 845XT, the standard mercury sphygmomanometer and the London School of Hygiene device. Clin Exp Hypertens 1989; 10: 575–588
- Brenner BM, Laragh JH. Biologically active atrial peptides. Raven Press, New York 1987; Vol 1, American Society of Hypertension symposium Series
- Trovati M, Massucco P, Cavalot F, Mularoni E, Mattiello L, Rocca G, Emanueli G. Insulin influences the renin-angiotensin-aldosteron system in humans. Clin exper metab 1989; 38: 501–3
- Sieber C, Gnädinger M, Del Pozo E, Shaw S, Weidmann P. Effect of a new somatostatin analogue SMS 201–995 (Sandostatin) on the renin-aldosterone axis. Clin Endocrinol (Oxf) 1988; 28: 25–32
- Nakaoka H, Kitahara Y, Amano M, Kouji I, Fujii J, Ishibashi M, et al. Effect of β-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 1987; 10: 221–25
- Testaert E, Cusson JR, Phancuf DC, Essiambre R, Lemire F, Hamet P, Thibault G, Larochelle P. Echocardiographic measurements and plasma levels of atrial natriuretic factor. J Cardiovasc Pharmacol 1989; 13(Suppl, 6)S47–S50
- Phillips RA, Ardeljan M, Shimabukuro S, Goldman ME, Garbowit DL, Eison HB, et al. Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension. J Am Coll Cardiol 1991; 17: 1595–1602
- Haak T, Jungmann E, Hannappel B, Schöffling K. Die Wirkung des atrialen natriuretischen Peptids auf Glucosetoleranz und Insulinspiegel. (The effect of atrial natriuretic peptide on glucose tolerance and insulin level). Med Klin 1990; 85: 61–64
- Pyörälä K, Uusitupa M, Laakso M. Macrovascular complications in relation to hyperinsulinemia in non-insulin-dependent diabetes mellitus. Diabete & Metabolisme 1987; 13: 345–349
- Andersson O, Hansson L., Sivertsson R. Primary Hypertension Refractory to Triple Drug Treatment- a Study on Central and Peripheral Hemodynamics. Acta Med Scand 1979, Suppl: 19–21
- Heinrich HA, Romen W, Heimgartner W, Harten E, Baumer F. Capillary rarefaction characteristics of the skeletal muscle of hypertensive patients. Klin. Wochenschr. 1988; 66: 54–60
- Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987; 80: 415–24
- Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85: 1844–52